FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377695983> ?p ?o ?g. }

• W4377695983 endingPage "109504" @default.
• W4377695983 startingPage "109504" @default.
• W4377695983 abstract "ALPS is a congenital disorder secondary to defects of FASmediated apoptosis, usually showing during the first years of life with variable phenotype, mainly characterized by lymphoproliferation and autoimmunity. Most patients carry mutation on FAS gene, more rarely defects on FASL/CASP10 are involved. Very few cases of ALPS-CASP10 have been reported, therefore clinical and immunological characteristics of such patients need to be better defined. Some mutations with a role in the pathogenesis of the disease have been reported over the years (Leu285Phe, Ile406Leu). Although others with conflicting interpretation have been afterwards classified as polymorphisms (Val410Ile, Tyr446Cys), nonetheless they have been associated with a defective apoptosis function. The aim of this study is to describe the phenotype of a cohort of patients carrying CASP10 variants. The clinical and immunological parameters included in the ALPS diagnostic criteria were evaluated as CD3+TCRaβ+CD4-CD8- (DNTs), the biomarkers (IL10,IL-18,sFAS, Vitamin B12), the ALPS panel signature (high DNT, high DNTsB220+, and low CD27+, low CD3+CD25+/CD3+HLADR+ ratio), and the apoptosis test. Thirty-two patients aged 0–53 years (median 10.9) were studied. Six carried the known Ile406Leu mutation, 11 presented some unreported variants as Cys401Leufs* (3), Pro501Leu (4), Ser239Cys (1), Arg104*(2), c684+4G>A (1). The remaining 16 carried polymorphic variants. Overall, only 18 patients (56%) showed lymphoproliferation and/or splenomegaly. Twenty-seven patients (84%) showed autoimmune features including autoimmune cytopenia (65%) in 19 cases. DNTs were raised in 64% of cases and apoptosis test was positive in 74% of patients including all cases with novel mutations. Five (15%) patients showed hypogammaglobulinemia. Twelve (37%) and 10/32 (31%) patients showed an ALPS and ALPS-like phenotype, respectively. The remaining 10 (31%) presented a different immune-dysregulation pattern. Two patient (6%) developed a lymphoma. Table 1 shows details of clinical and immunological characteristics. Median follow-up was 5.9 years (0.5–24). This is the largest reported cohort of patients carrying CASP10 variants showing that most of them have a clinical phenotype other than ALPS, mainly presenting with milder immune dysregulation showing at older age. Due to this different clinical pattern, ALPS diagnostic criteria should be reviewed and patients with CASP10 variants should be considered as having a different disorder.Table 1. Clinical and immunological characteristics of patients carrying CASP10 variants.Empty CellTotal (З2)Casp10 polymorphic variants (16)Casp10 pathogenic variants (16)pALPS phenotype12 (37%)6 (37%)6 (37%)nsALPS-like phenotype10 (31%)6 (37%)4 (25%)nsOther immunedysregulation10 (31%)4 (25%)6 (37%)nsIL-1S >(500 pg/mL)10 (31%)7 (44%)3 (19%)<0.05B12(>663 pg/mL)11 (34%)5 (31%)6 (37%)nsIL-10 (>20 pg/mL)1 (3%)1 (6%)0 (0%)nssFAS ligand (>200 pg/mL)0 (0%)0 (0%)0 (0%)nsDNT cells (%CD3) (>1,5%)21 (65%)10 (62%)11 (69%)nsCD3CD25+/CD3HLADR+ ratio (<1%)21 (65%)10 (62%)11 (69%)nsTCR αβ+ B220+ (>60%)10 (31%)5 (31%)4 (25%)nsLinfoB CD27+ (CD19tot) (<15%)20 (62%)11 (69%)9 (56%)nsALPS Panel positive 4/45 (15%)3 (19%)2 (12%)ns Table 1. Clinical and immunological characteristics of patients carrying CASP10 variants." @default.
• W4377695983 created "2023-05-24" @default.
• W4377695983 creator A5002533751 @default.
• W4377695983 creator A5008781654 @default.
• W4377695983 creator A5010090533 @default.
• W4377695983 creator A5030709969 @default.
• W4377695983 creator A5038019019 @default.
• W4377695983 creator A5039355289 @default.
• W4377695983 creator A5042998256 @default.
• W4377695983 creator A5048677524 @default.
• W4377695983 creator A5056856566 @default.
• W4377695983 creator A5060449177 @default.
• W4377695983 date "2023-05-01" @default.
• W4377695983 modified "2023-10-18" @default.
• W4377695983 title "Clinical and immunological phenotype of patients caryying CASP10 variants" @default.
• W4377695983 doi "https://doi.org/10.1016/j.clim.2023.109504" @default.
• W4377695983 hasPublicationYear "2023" @default.
• W4377695983 type Work @default.
• W4377695983 citedByCount "0" @default.
• W4377695983 crossrefType "journal-article" @default.
• W4377695983 hasAuthorship W4377695983A5002533751 @default.
• W4377695983 hasAuthorship W4377695983A5008781654 @default.
• W4377695983 hasAuthorship W4377695983A5010090533 @default.
• W4377695983 hasAuthorship W4377695983A5030709969 @default.
• W4377695983 hasAuthorship W4377695983A5038019019 @default.
• W4377695983 hasAuthorship W4377695983A5039355289 @default.
• W4377695983 hasAuthorship W4377695983A5042998256 @default.
• W4377695983 hasAuthorship W4377695983A5048677524 @default.
• W4377695983 hasAuthorship W4377695983A5056856566 @default.
• W4377695983 hasAuthorship W4377695983A5060449177 @default.
• W4377695983 hasConcept C104317684 @default.
• W4377695983 hasConcept C127716648 @default.
• W4377695983 hasConcept C167672396 @default.
• W4377695983 hasConcept C190283241 @default.
• W4377695983 hasConcept C203014093 @default.
• W4377695983 hasConcept C2780942790 @default.
• W4377695983 hasConcept C31573885 @default.
• W4377695983 hasConcept C54355233 @default.
• W4377695983 hasConcept C66008609 @default.
• W4377695983 hasConcept C71924100 @default.
• W4377695983 hasConcept C86803240 @default.
• W4377695983 hasConcept C8891405 @default.
• W4377695983 hasConceptScore W4377695983C104317684 @default.
• W4377695983 hasConceptScore W4377695983C127716648 @default.
• W4377695983 hasConceptScore W4377695983C167672396 @default.
• W4377695983 hasConceptScore W4377695983C190283241 @default.
• W4377695983 hasConceptScore W4377695983C203014093 @default.
• W4377695983 hasConceptScore W4377695983C2780942790 @default.
• W4377695983 hasConceptScore W4377695983C31573885 @default.
• W4377695983 hasConceptScore W4377695983C54355233 @default.
• W4377695983 hasConceptScore W4377695983C66008609 @default.
• W4377695983 hasConceptScore W4377695983C71924100 @default.
• W4377695983 hasConceptScore W4377695983C86803240 @default.
• W4377695983 hasConceptScore W4377695983C8891405 @default.
• W4377695983 hasLocation W43776959831 @default.
• W4377695983 hasOpenAccess W4377695983 @default.
• W4377695983 hasPrimaryLocation W43776959831 @default.
• W4377695983 hasRelatedWork W1997910410 @default.
• W4377695983 hasRelatedWork W2351839987 @default.
• W4377695983 hasRelatedWork W2372065906 @default.
• W4377695983 hasRelatedWork W2375195996 @default.
• W4377695983 hasRelatedWork W2376876873 @default.
• W4377695983 hasRelatedWork W2382761630 @default.
• W4377695983 hasRelatedWork W2386741002 @default.
• W4377695983 hasRelatedWork W2403788804 @default.
• W4377695983 hasRelatedWork W2436090554 @default.
• W4377695983 hasRelatedWork W2473169874 @default.
• W4377695983 hasVolume "250" @default.
• W4377695983 isParatext "false" @default.
• W4377695983 isRetracted "false" @default.
• W4377695983 workType "article" @default.